SCHEMBL15760438

SCHEMBL15760438

CCOC(=O)c1c(CC)nc2cnccn12

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 3/20 0.48
SMN1; SMN2 Q16637 3/20 0.44
CYP2C9 P11712 3/20 0.44
CYP2C19 P33261 3/20 0.44
CYP1A2 P05177 2/20 0.44
ALDH1A1 P00352 5/20 0.44
KDM4E B2RXH2 4/20 0.44
HPGD P15428 4/20 0.44
HSD17B10 Q99714 3/20 0.44
GAA P10253 3/20 0.43
CASP1 P29466 2/20 0.43
CASP7 P55210 2/20 0.43
ALOX15 P16050 2/20 0.43
BRAF P15056 1/20 0.43
RAB9A P51151 3/20 0.42
NPC1 O15118 2/20 0.42
KMT2A Q03164 2/20 0.39
MAPT P10636 2/20 0.39
HCRTR1 O43613 1/20 0.39
TP53 P04637 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18357422 0.88 DAPK3 (0.41) MAPK1ALDH1A1KDM4EHPGDHSD17B10
SCHEMBL1965048 0.86 MAPK1 (0.64) MAPK1SMN1; SMN2CYP2C9CYP2C19CYP1A2
SCHEMBL15760437 0.83 GAA (0.37) MAPK1ALDH1A1KDM4EHPGDHSD17B10
SCHEMBL12295364 0.80 MAPK1 (0.75) MAPK1SMN1; SMN2CYP2C9CYP2C19CYP1A2
SCHEMBL20579817 0.79 CYP1A2 (0.74) MAPK1SMN1; SMN2CYP2C9CYP2C19CYP1A2
SCHEMBL20181666 0.78 MAPT (0.43) ALDH1A1KDM4EHPGDHSD17B10GAA
SCHEMBL20181578 0.78 CYP19A1 (0.46) ALDH1A1KDM4EGAAALOX15KMT2A
SCHEMBL26527678 0.76 RAB9A (0.51) MAPK1SMN1; SMN2CYP2C9CYP2C19CYP1A2
SCHEMBL26626578 0.76 RAB9A (0.51) MAPK1SMN1; SMN2CYP2C9CYP2C19CYP1A2
SCHEMBL18920834 0.76 ALDH1A1 (0.48) MAPK1ALDH1A1KDM4EHPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9029389-B2 Anti-inflammation compounds INSTITUT PASTEUR KOREA (KR) 2015-05-12 US disclosed
US-9029389-B2 Anti-inflammation compounds INSTITUT PASTEUR KOREA (KR) 2015-05-12 US disclosed
US-20140155387-A1 Anti-Inflammation Compounds QURIENT, CO. LTD. (KR) 2014-06-05 US disclosed
US-20140155387-A1 Anti-Inflammation Compounds QURIENT, CO. LTD. (KR) 2014-06-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140155387-A1 Anti-Inflammation Compounds NR0B1, NR0B2, NR5A2 MAPK1 1756/4885SMN1; SMN2 3238/4885CYP2C9 1210/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.